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Zinc is essential to a wide range of cellular processes;
therefore, it is important to elucidate the molecular
mechanisms of zinc homeostasis. To date, no zinc trans-
porters expressed at the enterocyte apical membrane,
and so essential to mammalian zinc homeostasis, have
been discovered. We identified hZTL1 as a human ex-
pressed sequence tag with homology to the basolateral
enterocyte zinc transporter ZnT1 and deduced the full-
length cDNA sequence by PCR. The protein of 523 amino
acids belongs to the cation diffusion facilitator family of
membrane transporters. Unusually, the predicted topol-
ogy comprises 12 rather than 6 transmembrane do-
mains. ZTL1 mRNA was detected by reverse transcrip-
tion-PCR in a range of mouse tissues. A Myc-tagged
hZTL1 clone was expressed in transiently transfected
polarized human intestinal Caco-2 cells at the apical
membrane. Expression of hZTL1 mRNA in Caco-2 cells
increased with zinc supplementation of the nutrient me-
dium; however, in the placental cell line JAR hZTL1
appeared not to be regulated by zinc. Heterologous ex-
pression of hZTL1 in Xenopus laevis oocytes increased
zinc uptake across the plasma membrane. The localiza-
tion, regulatory properties, and function of hZTL1 indi-
cate a role in regulating the absorption of dietary zinc
across the apical enterocyte membrane.
The involvement of zinc in a diverse array of cellular pro-
cesses highlights the importance of understanding mechanisms
of zinc homeostasis. Zinc is a catalytic and/or structural cofac-
tor for several hundred metalloproteins, including zinc met-
alloenzymes and transcription factors. Central to cellular zinc
homeostasis is likely to be the activity of membrane transport-
ers that mediate cellular zinc uptake and efflux as well as
intracellular zinc sequestration. To date, the identity of the
zinc transporter most likely to play the major role in mamma-
lian zinc homeostasis, the transporter expressed at the apical
membrane of the enterocyte, has proved elusive. Most eukary-
otic cDNAs cloned to date that encode proteins with zinc trans-
port activity fall into one of two main groups.
The ZIP family of transporters, which included initially the
yeast proteins ZRT1 (1), ZRT2 (2), and the Arabidopsis iron
transporter IRT1 (3), now includes human proteins hZip1 and
hZip2 (4, 5) plus Arabidopsis transporters Zip1–4 (6). The
ability to mediate cellular zinc uptake appears to be a common
function of this group of transporters. Consistent with a role in
zinc uptake, the yeast high affinity transporter ZRT1 is in-
duced by zinc restriction (1). All members listed above of this
group of proteins share the same predicted topology; that is,
eight membrane-spanning domains with extracellular N and C
termini. Conserved histidine residues and polar or charged
amino acids that lie close to these histidines in the predicted
structure in transmembrane domains IV and V have been
shown in IRT1 to be essential for transport function (7).
The properties and localization of members of a second group
of proteins, the cation diffusion facilitator (CDF)1 family, are
consistent with a role in zinc efflux or intracellular sequestra-
tion in vesicles/vacuoles. Most genes in this diverse family,
which is defined by a specific sequence motif (8), were cloned as
a result of conferring resistance to transition metal toxicity.
The CDF family includes ZRC1, which confers zinc resistance
in yeast (9), and COT1, a yeast cobalt transporter (10), plus the
mammalian proteins ZnT1–4 (11–14). Common to most mem-
bers of the CDF family is a predicted transmembrane structure
comprising six membrane-spanning domains with intracellular
N and C termini and, in the case of eukaryotic members, a
histidine-rich intracellular loop that represents a potential zinc
binding region (8). Although the published data are consistent
with a direct role for mammalian CDF-family transporters in
mediating zinc transport, this has not been demonstrated di-
rectly by expression in a heterologous system. It remains a
possibility that CDF-family transporters are auxiliary factors
in zinc transport or subunits of a larger zinc transporter com-
plex (11). Consistent with a role in zinc transport are the
regulatory properties of ZnT1 and ZnT2. A severely zinc-re-
stricted diet led to reduced levels of ZnT2 mRNA expression in
rat kidney and intestine, whereas a diet supplemented with
zinc or a single oral dose of zinc led to increased abundance of
ZnT1 and ZnT2 mRNAs in both tissues (15).
There has been debate over a role for the divalent cation
transporter DMT1 (also referred to as Nramp2 or DCT1) in
cellular zinc uptake. Heterologously expressed rat DMT1 has
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been demonstrated to mediate proton-coupled uptake of Fe2
into Xenopus laevis oocytes, and the divalent cations Fe2,
Zn2, Cd2, Mn2, Cu2, Co2, Ni2, and Pb2 all evoked
inward currents in this expression system (16). However, it has
since been established that Fe2 and Zn2 are transported
across the apical membrane of the intestinal Caco-2 cell line by
distinct mechanisms. Zinc did not inhibit DMT1-mediated Fe2
uptake in this system nor was Zn2 uptake affected by reduced
expression of DMT1 (17). Furthermore, whereas DMT1-medi-
ated transport is coupled to proton co-transport, uptake of zinc
by small intestinal brush border membrane vesicles was inhib-
ited by an inwardly directed H gradient (18).
Transport of zinc by the enterocyte from the gut lumen to the
blood is essential to mammalian zinc homeostasis. The symp-
toms of the zinc deficiency disease acrodermatitis entero-
pathica (AE), a rare autosomal recessive genetic abnormality,
result from zinc malabsorption (19). ZnT-1, expressed at the
basolateral membrane (20), may be involved in mediating zinc
transport from enterocyte to blood. ZnT-4 is expressed in rat
intestine in the membrane of intracellular vesicles (21) and
ZnT-2, whose RNA can be detected in intestine, is similarly
localized in baby hamster kidney cells (12) and probably, there-
fore, also in intestine. ZnT3 is expressed only in brain and
testis (13). HZIP1, localized to the plasma membrane in K562
erythroleukemia cells (4), has recently been demonstrated to
have a vesicular localization in the human intestinal Caco-2
cell line (22), ruling out a role in mediating zinc transport
across the enterocyte brush border membrane. HZIP2 has been
detected only in prostate and uterus (5). To our knowledge, it
has yet to be demonstrated that any of the ZIP or CDF family
zinc transporters cloned to date are localized at the apical
enterocyte membrane. The human natural resistance-associ-
ated macrophage protein 1 (Nramp1) shows a high degree of
homology to DMT1 and is a functional zinc transporter (23).
However, Nramp1 is expressed exclusively in macrophages
(24). Thus, the identity of the transporter primarily responsible
for dietary zinc uptake in mammals remains unknown.
We report the cloning of a novel human zinc transporter
expressed at the apical membrane of the Caco-2 human small
intestinal cell line model, whose sequence places it within the
CDF family but which has apparently different topology from
the other cloned mammalian members. We propose that this
protein represents the first member of a new subfamily of
mammalian zinc transporters and refer to the transporter as
hZTL1 (human ZnT-Like transporter 1). We show mouse ZTL1
to have widespread tissue distribution and demonstrate differ-
ential regulation by zinc of hZTL1 mRNA expression levels in
cultured intestinal and placental cell lines. We present data
confirming the predicted functional activity of hZTL1 with
respect to zinc transport.
EXPERIMENTAL PROCEDURES
Rapid Amplification of cDNA Ends (RACE)—A pair of nested reverse
primers, 286GTTTGGATGGTTCATCGCTGACCCAC261 and 197GCCAG-
GTTCTACTCCTGAGATTGCCACC170, annealing to an EST (Gen-
BankTM accession number AA993841) identified through homology at
the protein level to mouse ZnT1, was designed and used for 5-RACE.
5-RACE was carried out from human small intestine Marathon-
ReadyTM cDNA (CLONTECH) following the manufacturer’s instruc-
tions and using the Advantage cDNA polymerase mix (CLONTECH) as
recommended. Thermal cycling parameters for the first round of am-
plification were: 94 °C for 30 s; 5 cycles at 94 °C for 5 s, 72 °C for 4 min;
5 cycles at 94 °C for 5 s, 70 °C for 4 min; 25 cycles at 94 °C for 5 s, 68 °C
for 4 min. Cycling parameters were the same for the nested reaction,
but the final cycle number was reduced to 20.
The product, 2 kb in size, was subcloned into the vector pCR2.1
TOPO (Invitrogen) for sequencing. Sequencing was carried out by the
Molecular Biology Facility, University of Newcastle using an ABI Prism
model 377 automated sequencer.
RNA Preparation—RNA was prepared from cells and tissues using
RNAzol B (Biogenesis) following the manufacturer’s instructions.
Generation of an hZTL1 cDNA Clone—A cDNA clone of hZTL1 cod-
ing for all but the 42 C-terminal-most amino acids was generated by
nested RT-PCR from Caco-2 mRNA. Reverse transcription was for 2 h
at 42 °C using Moloney murine leukemia virus reverse transcriptase
(Invitrogen) (2 units/l) in the manufacturer’s buffer (50 mM Tris-HCl
(pH 8.3), 50 mM KCl, 4 mM MgCl2) containing 1 mM dithiothreitol, 0.5
mM dNTPs, 0.001 units/l hexanucleotide primer, and 1.5 units/l
ribonuclease inhibitor. Reactions were terminated by heating to 95 °C
for 5 min, and cDNA was amplified initially over 30 cycles (94 °C for 30
s, 50 °C for 30 s, 72 °C for 90 s) in a PCR reaction mixture containing 0.2
mM dNTPs, 0.5 mM each primer (670GCTGTGATCTGTTTATTGC688
and 2274GGTTGTCTGTTTTACTTCCAG2254), and 1 Advantage cDNA
polymerase mix (CLONTECH) in the manufacturer’s buffer (40 mM
Tricine-KOH (pH 9.2), 15 mM potassium acetate, 3.5 mM magnesium
acetate, 3.75 g/ml bovine serum albumin). The nested PCR reaction
was as for the first round of amplification but using the primer pair
694GACAATGATGATCTCATGGC713 and 2152GCAATCTCAGGAGTA-
GAAC2134 and an annealing temperature of 56 °C. The 1459-bp cDNA
fragment was sub-cloned into the vector pCR2.1 TOPO (Invitrogen) to
give the plasmid pZTL1–50. The sequence of the clone was confirmed as
above. Attempts to generate a clone that included the entire C-terminal
region were unsuccessful.
Northern Blotting—Twenty micrograms of total RNA prepared from
Caco-2 cells were run on a 1.2% formaldehyde-containing agarose gel,
transferred to a nylon membrane (Hybond N, Amersham Biosciences)
by capillary electrophoresis, and fixed by UV cross-linking. The mem-
brane was prehybridized at 42 °C in 50% formamide, 2 SSPE (300 mM
NaCl, 20 mM NaH2PO4, 2 mM EDTA (pH 7.4)), 5 Denhardt’s reagent,
0.5% (w/v) SDS, 100 g/ml sonicated salmon sperm DNA (Sigma) and
then hybridized for 16 h in the same buffer containing 25 ng of 32P-
labeled cDNA probe. The probe comprised the 1521-bp fragment includ-
ing the hZTL1 cDNA sequence removed using EcoRI from pZTL1–50.
The membrane was washed at 65 °C in 2 SSC (300 mM NaCl, 30 mM
sodium citrate), 0.1% SDS and examined by electronic autoradiography
using a Packard Instant Imager.
Sequencing of hZTL1 in AE Patients—The group of 20 AE patients
who form the basis of this study was recruited from 12 families from
France and Tunisia. Each patient was individually examined by an
experienced dermatologist to confirm the diagnosis of AE. After obtain-
ing informed consent, anticoagulated venous blood was sampled from
each patient and used for direct DNA preparations. High molecular
weight genomic DNA was isolated using the Nucleon BACC2 kit ac-
cording to the manufacturer’s protocol (Amersham Biosciences). For
each of the 20 AE patients, the 11 exons of hZTL1 were PCR-amplified
using 20 ng of genomic DNA per reaction, and primers were designed in
the flanking intronic regions at 50 bp or more from the splice sites. PCR
amplifications were initiated by a denaturation of 10 min at 94 °C
followed by 5 cycles of 45 s at 94 °C, 20 s at 5 °C over the annealing
temperature and 90 s at 72 °C then by 25 cycles of 45 s at 94 °C, 20 s at
annealing temperature and 90 s at 72 °C with a final extension at 72 °C
for 10 min. PCR products were sequenced automatically (ABI 377
sequencing system using Thermo Sequenase II Dye Terminator cycle
sequencing premix kit, Amersham Biosciences).
Culture of Mammalian Cells—Caco-2 cells (passage 30) were seeded
into 25-cm2 flasks at a density of approximately one million cells per
flask and maintained at 37 °C in a humidified atmosphere of 5% CO2 in
air in Dulbecco’s modified Eagle’s medium (with 4.5 g/liter glucose)
supplemented with 10% (v/v) fetal calf serum, 60 g/ml gentamycin, 2
mM L-glutamine, and 1% (v/v) nonessential amino acids. All tissue
culture reagents were supplied by Sigma. The medium was replaced
twice weekly. For growth at increased concentrations of zinc, ZnCl2 was
added to the culture medium, progressively increasing the concentra-
tion from 3 M (standard medium, measured using a Unicam 701
inductively coupled plasma optical emission spectrometer) to 20, 50,
and, finally, 100 M. This approach was necessary because ZnCl2 at 100
M added to non-conditioned cells proved toxic. For growth at 20 M
ZnCl2, the salt was added to a confluent cell monolayer (14 days post-
seeding) for 7 days before passaging cells by the addition of 0.05% (w/v)
trypsin, 0.2% EDTA in Earle’s balanced salt solution (Sigma). Newly
seeded cells were then maintained for a further 7 days at 20 M ZnCl2
before increasing the ZnCl2 concentration to 50 M. Cells were passaged
after an additional 7 days of growth and maintained for a further 7 days
at 50 M ZnCl2. The ZnCl2 concentration of the nutrient medium was
then increased to 100 M and cells were maintained at this concentra-
tion for 7 days before harvesting RNA.
JAR cells were cultured as described above for Caco-2 cells with a
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number of modifications. Nutrient medium comprised RPMI 1640 (In-
vitrogen) supplemented with 2 mM L-glutamine, 10% fetal calf serum,
and penicillin/streptomycin (100 units/ml and 100 g/ml, respectively).
Seeding density was 2.5  106 cells/cm2. Cells were passaged every 7
days. JAR cells were able immediately to tolerate ZnCl2 added to the
nutrient medium at a concentration of 100 M. ZnCl2 was added to cells
1 day post-seeding, and cells were maintained in this medium for 6 days
before harvesting RNA.
Detection of hZTL1 Localization by Transient Transfection of Caco-2
Cells—A construct for the expression in mammalian cells of hZTL1
tagged at the C terminus with the Myc epitope was produced by EcoRI
digestion of plasmid pZTL1–50 followed by ligation of the gel-purified
(Nucleospin kit, CLONTECH) 1476-bp fragment into the plasmid
pCDNA3.1/Myc-His A (Invitrogen) to give the plasmid pZTL1-Myc.
For transfection, Caco-2 cells were seeded at a density of 5  105
cells/cm2 onto polycarbonate tissue culture inserts (0.4-m pore, 12-mm
diameter, Costar) and cultured for 14 days until differentiated. The
plasmid pZTL1-Myc was precipitated by the addition of 1 g DNA in
250 mM CaCl2 to an equal volume of HEPES-buffered saline (pH 7.05;
280 mM NaCl, 50 mM HEPES, 1.5 mM Na2HPO4). A 400 l volume of
this mixture was then added to cells in 3 ml of complete nutrient
medium in the upper chamber only. Medium was then removed after
8 h, and cells were treated with 10% glycerol in complete medium for 4
min. Cells were washed twice in phosphate-buffered saline and main-
tained in complete medium for 48 h. Cells were fixed for 5 min in
methanol at room temperature. The hZTL1-fused Myc epitope was
detected using fluorescein isothiocyanate-conjugated anti-Myc antibody
(Invitrogen) following the manufacturer’s instructions. Nuclei were
stained by incubation with 5 g/ml propidium iodide in phosphate-
buffered saline for 5 min, and cells were then mounted in Vectashield
fluorescence mounting medium (Vector Laboratories Ltd). The pattern
of fluorescence was visualized by confocal laser-scanning microscopy.
Semi-quantitative RT-PCR—Co-amplification of hZTL1 or metallo-
thionein mRNA and 18 S rRNA was carried out using the GeneAmp
RNA PCR core kit (Applied Biosystems) following the manufacturer’s
instructions and using either the hZTL1-specific primers 1939GGTG-
GAGGCATGAATGCTA1957 and 2160TTCTGGCAATCTCAGG2142 or the
metallothionein-specific primers 24ATGGACCCAACTGCTCC41 and
209TCAGGCACAGCAGCTGCAC191 (GenBankTM accession number
XM_048212) along with 18 S rRNA-specific primers (Ambion) with
thermal cycling parameters: 95 °C, 30 s; 57 °C, 30 s; 72 °C, 60 s for
hZTL1 amplification and 95 °C, 30 s; 59 °C, 30 s; 72 °C, 90 s for metal-
lothionein amplification. PCR cycle number was limited to within an
experimentally determined linear range of amplification (35 cycles for
hZTL1; 33 cycles for metallothionein). 18 S rRNA primers modified at
their 3 end so as to render them non-extendable (Classic Quantum
RNA 18 S Internal Standards, Ambion) were also included in the
reaction at an appropriate ratio determined empirically to reduce the
intensity of the 18 S rRNA band (when viewed after agarose gel elec-
trophoresis) to within the range of the hZTL1 band and thus enable
accurate normalization of the hZTL1-specific product against 18 S
rRNA.
In Vitro Transcription of hZTL1 cRNA—The plasmid pZTL1–50 was
linearized 3 of the hZTL1 insert using the restriction endonuclease
SstI. Complementary RNA was transcribed from the T7 promoter up-
stream of the hZTL1 cDNA using the mMessage mMachine kit (Am-
bion) following the manufacturer’s instructions.
Measurement of hZTL1 Activity in X. laevis Oocytes—Oocytes (stage
V or VI) were isolated from ovarian tissue obtained from mature female
X. laevis toads (S. African Xenopus facility) as described previously (25).
Tissue was digested with 2 mg/ml collagenase A (Roche Molecular
Biochemicals) in Ca2-free modified Barth’s medium (88 mM NaCl, 1
mM KCl, 2.4 mM NaHCO3, 0.82 mM MgSO4, 20 mM HEPES/Tris (pH
7.6), 10 mg/ml gentamycin) at 22 °C for 3 h with gentle agitation.
Oocytes were injected with 50 nl of either deionized water or hZTL1
cRNA (2 g/ml) and left for 3 days at 18 °C in modified Barth’s medium
(88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.82 mM MgSO4, 0.33 mM
Ca(NO3)2, 0.41 mM CaCl2, 20 mM HEPES/Tris (pH 7.6), 10 mg/ml
gentamycin) before measurement of zinc fluxes across the oocyte
plasma membrane. Zinc uptake into injected oocytes was measured by
incubating groups of 10–15 oocytes for 2 or 4 h in 300 l of modified
Barth’s medium plus 12 M ZnCl2 including 6.4 Ci/ml
65Zn2
(PerkinElmer Life Sciences). Oocytes were washed 3 times in deionized
water before measuring 65Zn2 incorporation into single oocytes using a
 counter.
Bioinformatics Tools—Sequence alignments were performed using
BLAST (26). A putative transmembrane topology for hZTL1 was de-
rived using TMpred, an algorithm based on statistical analysis of the
TMbase data base of naturally occurring transmembrane protein seg-
ments using maximum and minimum values of 29 and 19, respectively,
for the length of the hydrophobic region of the membrane helix (27).
Analysis of the hZTL1 peptide sequence for conserved motifs, O-glyco-
sylation sites, and signal peptide sequences was by the use of Inter-
ProScan (28), NetOglyc (29), and SignalP (30) respectively. Genomic
sequence between regions corresponding to the hZTL1 cDNA clone was
screened for additional exons using FGENE (31) and FEX (32).
RESULTS
The Sequence and Gene Structure of a Novel Zinc Trans-
porter, hZTL1—The cDNA sequence of a putative novel zinc
transporter identified initially as a 3 EST with homology at
the protein level to ZnT1 was determined by 5-RACE from a
human intestinal cDNA library. Assuming the first in-frame
ATG codon to be the start of translation, the open reading
frame codes for a protein of 523 amino acids (Fig. 1A) and the
cDNA clone includes 708 bp of the 5-untranslated region. The
sequence around the ATG at position 709, however (CT-
CATGG), deviates from the Kozak consensus sequence (RXX-
ATGG), whereas a second in-frame ATG at position 718
(AAAATGG) concurs with the Kozak consensus sequence.
Translation from this potential start codon would produce a
protein truncated at the N terminus by three amino acids in
comparison to the sequence we state. Amino acid residues
271–287 (Fig. 1B) comprise the CDF signature sequence (8),
thus placing this protein within the CDF family. Topology
prediction using TMpred (or alternatively, TMAP (33)) indi-
cates 12 membrane-spanning domains with extracellular N
and C termini and a histidine-rich intracellular loop, poten-
tially involved in zinc binding, between transmembrane do-
mains IX and X. This conformation is favored over a possible
alternative with cytoplasmic N and C termini both by compar-
ison with the TMbase data base of naturally occurring trans-
membrane protein segments (27) and by homology with ZnT
family members. HZTL1 shows 34% identity to ZnT1 over a
stretch of 122 amino acids (Fig 1B). The region of homology
spans transmembrane domains I- IV in ZnT1 and domains VI-
IX in hZTL1 (Fig. 1C). Intracellular N and C termini would
reverse the orientation of the transmembrane domains in
hZTL1 with respect to their homologous domains in ZnT1 and,
furthermore, would position the histidine-rich loop in an un-
characteristic extracellular position. The region best conserved
across all members of the CDF family encompasses transmem-
brane domains I- IV of the typical, six-transmembrane domain
structure (8). Identity between hZTL1 and other members of
the ZnT family is as follows; for rat ZnT2, 22% over a region 239
amino acids in length; for mouse ZnT3, 21% identity over a
stretch of 244 amino acids; for mouse ZnT4, 25% identity over
a region of 252 amino acids. As for ZnT1, this homology is due
to alignment of transmembrane domains I- IV in the ZnT
transporters with transmembrane domains IV- IX of hZTL1
but also due to homology between transmembrane domains V
and VI of the ZnT transporters and transmembrane domains X
and XI of hZTL1. Analysis of the amino acid sequence of hZTL1
reveals no nucleotide binding motifs, no predicted sites for O-
or N-glycosylation, and no apparent signal peptide or mito-
chondrial targeting sequence.
Alignment of the hZTL1 cDNA sequence with the draft hu-
man genome sequence localizes the gene on chromosome 5
(position 77269K-77651K). The deduced gene structure is
shown in Fig. 2. The appearance on a Northern blot of Caco-2
RNA probed with hZTL1 cDNA of two bands (Fig. 2C) suggests
alternatively spliced hZTL1 transcripts. Analysis of the inter-
exon sequence on chromosome 5 indicates no additional poten-
tial exons between exons 3 and 11. However, the regions des-
ignated introns 1 and 2 include additional potential coding
sequence, possibly suggesting N-terminal splice variants. It is
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also possible that additional exons 3 of exon 11 contribute to
the larger transcript. The TATA box consensus sequence
TATAAAA lies 71 nucleotides upstream of the 5 end of the
hZTL1 cDNA clone. This putative TATA box, an element that is
characteristically centered 25 bases upstream of the start of
transcription, possibly indicates that the 5-UTR of the cDNA
clone is incomplete. The promoter region of the hZTL1 gene
includes core, consensus metal response element (MRE) se-
quences (TGCRCNC) centered at positions 461, 645, 1238,
2257, and 3250 nucleotides upstream of the start of the cDNA
sequence. The sequences at positions 645 and 3250 are in
the forward orientation, whereas those at 461, 1238, and
2257 are in the reverse orientation. MRE binding transcrip-
tion factor 1 (MTF-1) is known to regulate basal and zinc-
induced expression of metallothionein in cultured cells (34) and
to mediate zinc induction of metallothionein expression in vis-
ceral endoderm cells during early development in utero of the
mouse (35).
A recent report placing the AE locus in the majority of
patients analyzed (from Jordanian and Egyptian populations)
on chromosome 8 (36) excludes the possibility that a mutation
in hZTL1 is responsible for the disease in these subjects. How-
ever, for two cases in this study the AE syndrome appeared not
to be linked to the same locus (36); thus, it is possible that other
loci are responsible for some forms of AE. We therefore inves-
tigated the possibility that a mutation in hZTL1 might account
for the symptoms of AE in patients not carrying the disease-
linked markers on chromosome 8. Three SNPs in the coding
FIG. 1. The hZTL1 amino acid sequence and predicted topology. A, theoretical translation of the hZTL1 cDNA sequence (GenBankTM
accession number AF39324), indicating the 12 predicted transmembrane regions. B, alignment of the hZTL1 amino acid sequence with the
sequence of mouse ZnT1. The CDF signature sequence is underlined. C, the predicted transmembrane topology of hZTL1. The shaded area
indicates the region of homology with ZnT1.
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region were noted (2 in exon 10, and 1 in exon 11); however,
none result in amino acid substitutions, and none correspond to
presence of the disease. Thus, we exclude the possibility that a
mutation in hZTL1 accounts for AE in the 12 families examined
in the present study. However, we cannot exclude definitively
that hZTL1 may be the molecular cause of AE for other unre-
lated families diagnosed with this disorder.
Expression Profile of hZTL1 in Mouse Tissues—ZTL1 mRNA
was detected by RT-PCR in all mouse tissues analyzed. Fig. 3A
shows the relative levels of expression of hZTL1 mRNA in these
tissues. We detected a difference in expression of 4-fold rela-
tive to 18 S rRNA between kidney, a tissue expressing ZTL1
mRNA at relatively high levels, and liver, which expresses a
relatively low level.
Subcellullar Localization of hZTL1—The localization of
hZTL1 in a confluent monolayer of Caco-2 cells maintained in
culture for 14 days to ensure differentiation was determined by
confocal laser-scanning microscopy to visualize a fluorescein
isothiocyanate-conjugated anti-Myc antibody after transfection
with a construct from which hZTL1 was expressed as a fusion
protein with the Myc epitope at the C terminus. A series of
sections parallel to the plane of the monolayer (a Z-series; Fig.
3B) and a section through a transfected cell perpendicular to
the monolayer (an XZ-section; Fig. 3C) demonstrate clearly
apical localization of anti-Myc immunoreactivity. Thus apical
localization of hZTL1 in the human enterocyte is indicated.
Regulation by Zinc of hZTL1 Expression Levels—The effect
of zinc availability on levels of expression of hZTL1 mRNA in
human intestinal Caco-2 cells was determined by culturing
cells at progressively increasing concentrations of zinc until
cells were able to tolerate 100 M ZnCl2. The zinc concentration
of standard nutrient medium was determined as 3 M by in-
ductively coupled plasma optical emission spectroscopy. After 7
days of growth in 100 M ZnCl2, cells expressed hZTL1 mRNA
at levels more than 2-fold greater than co-passaged controls
(Fig. 4A). Regulation by zinc of hZTL1 mRNA expression in the
human placental cell line JAR was also studied. Unlike Caco-2
cells, JAR cells were able to immediately tolerate an increase in
the ZnCl2 concentration of the nutrient medium from 3 to 100
M. We found that culturing JAR cells for 7 days at 100 M
rather than 3 M ZnCl2 resulted in no change in hZTL1 mRNA
levels (Fig. 4B). In both cell lines, levels of metallothionein
mRNA, known to be regulated by zinc (34), were increased at
100 M compared with 3 M ZnCl2 (Fig. 4, C and D).
Functional Activity of hZTL1—The ability of hZTL1 to me-
diate zinc transport into the cell was determined by functional
expression in X. laevis oocytes. Uptake of 65Zn2 into oocytes
showed a progressive increase over periods of at least 4 h (Fig.
5A, inset ii). The rate of uptake of 65Zn2 supplied at 12 or 50
M into oocytes injected with hZTL1 cRNA was significantly
greater than into water-injected controls (Fig. 5A) over a 4-h
period and was markedly inhibited by excess (10 mM) unlabeled
ZnCl2 in the uptake medium, demonstrating a saturable proc-
ess. An increase in uptake at 50 M compared with 12 M Zn2
demonstrates a relatively high Km. Assuming an oocyte volume
of 500 nl, the uptake of Zn2 at the rate measured would
potentially lead to an increase in intracellular Zn2 concentra-
tion after 4 h of 150 M. Thus Zn2 uptake appears to be
accumulative.
The rate of 65Zn2 uptake into both hZTL1 cRNA-injected
oocytes and water-injected controls was reduced at pH 5.5
compared with pH 7.6 (Fig. 5B). We observe that endogenous
Zn2 uptake is more sensitive to inhibition at acid pH (5.5)
than hZLT1-mediated Zn2 uptake, indicating that the two
mechanisms are functionally distinct. It also appears that
hZTL1-mediated 65Zn2 uptake is marginally favored at higher
pH (Fig. 5B). The slope of the plot of hZTL1-mediated 65Zn2
uptake against pH is significantly greater than zero (p  0.05
FIG. 2. The hZTL1 gene structure. A, alignment of the hZTL1 gene on chromosome 5. Heavy regions indicate exons (numbered). The position
of the start of translation (in intron 3) is indicated. B, the exon and intron structure of the hZTL1 gene based on the alignment shown in panel A.
C, a Northern blot of Caco-2 RNA probed with hZTL1 cDNA. The approximate sizes of hybridizing transcripts are indicated.
HZTL1, a Human Apical Intestinal Zinc Transporter 22793
by linear regression analysis), confirming uptake to be a pH-
dependent process.
DISCUSSION
We report the cloning of a novel zinc transporter whose
sequence places it within the CDF family of metal ion trans-
porters and which includes 12 putative transmembrane do-
mains. Although a six-transmembrane domain structure is
characteristic of CDF family proteins, a predicted structure
that includes 12 membrane-spanning domains is not without
precedent. The product of the yeast MSC2 gene, which belongs
to the CDF family and has recently been demonstrated to affect
cellular distribution of zinc (37), is also predicted to have 12
transmembrane domains. Homology with the other cloned
mammalian CDF proteins is such that hZTL1 might be re-
garded as a ZnT-type protein with an N-terminal extension of
five transmembrane domains. Interestingly, evidence based on
the properties of ZnT1 deletion mutants indicates that ZnT1 is
functional only as a multimer (11). It is therefore reasonable to
speculate that the N-terminal extension on hZTL1 might allow
functionality in the monomeric form.
Expression of hZTL1 tagged with the Myc epitope localized to
the apical membrane of human intestinal Caco-2 cells. The
Caco-2 cell line shows features typical of the enterocyte including
polarized localization to the appropriate membranes of a number
of proteins (38–40). We conclude, therefore, that hZTL1 also
localizes to the brush border membrane of the enterocyte in vivo.
We observed that increasing the Zn2 concentration of the
nutrient medium from 3 to 100 M resulted in up-regulation of
hZTL1 mRNA levels in human intestinal Caco-2 cells but not in
the human placental cell line JAR. The region upstream of the
hZTL1 cDNA sequence on chromosome 5 includes core consen-
sus MREs at positions 461, 645, 1238, 2257, and 3250.
Expression of hZTL1 may be regulated in Caco-2 cells by the
binding of the transcription factor MTF1 (34) to these MREs.
FIG. 3. Localization of hZTL1. A, relative levels of hZTL1 mRNA in a range of mouse tissues, expressed as a ratio of 18 S rRNA levels,
determined by semi-quantitative RT-PCR. Where error bars (S.D.) are included, values shown are the means of two independent experiments. B,
representative Z-series through Caco-2 monolayers transfected with hZTL1 cDNA tagged at the C terminus with the Myc epitope and probed with
fluorescein isothiocyanate-conjugated anti-Myc antibody (green). Red staining indicates nuclei stained with propidium iodide. Panels i through ix
show a series of sections through the monolayer passing from the apical to basolateral surface. The two series are from independent experiments.
Scale bar  10 m. C, an XZ section through a Caco-2 monolayer transfected with hZTL1 cDNA tagged at the C terminus with the Myc epitope
and probed with fluorescein isothiocyanate-conjugated anti-Myc antibody (green). Red staining indicates nuclei stained with propidium iodide. The
top of the panel is closest to the apical membrane. Scale bar  10 m.
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The more proximal MREs are stronger candidates for mediat-
ing zinc-regulated gene expression because of the proximal
location of the multiple MREs in the MTF1-regulated metallo-
thionein and ZnT1 genes (34, 41). The molecular basis for the
apparent differential sensitivity to zinc of hZTL1 expression in
intestine and placenta will be the subject of further study.
Without knowledge of the localization of hZTL1 in placenta,
one can only speculate on the rationale behind the different
regulatory responses of the hZTL1 gene in the two tissues to
changes in zinc availability. In intestine, increased levels of
hZTL1 expression in response to increased zinc availability
might facilitate more efficient uptake from a rich dietary sup-
ply. Tight homeostatic control of maternal circulating zinc con-
centration through regulated intestinal zinc absorption and by
mobilization from tissue stores may render unnecessary any
regulation by zinc availability of placental zinc transport.
Functional expression of hZLT1 in X. laevis oocytes is indi-
cated by measurement of increased uptake of 65Zn2 in oocytes
injected with hZTL1 cRNA, consistent with the view that
hZTL1 mediates zinc transport across the plasma membrane.
FIG. 4. Regulation by zinc of hZTL1 and metallothionein mRNA levels in Caco-2 and JAR cells. Histograms were obtained by
densitometric measurement of band intensities from the ethidium bromide-stained agarose gels shown above each. Bands were generated by
semi-quantitative RT-PCR from RNA samples extracted from cells grown in the presence of either 3 M Zn2 or 100 M Zn2 as indicated. Negative
control RT-PCR reactions identical to those yielding the products shown except for the omission of Moloney murine leukemia virus reverse
transcriptase resulted in no products. A, analysis of relative hZTL1 mRNA levels (222 bp) expressed as a ratio of 18 S rRNA levels (489 bp) in
Caco-2 cells; **, p  0.01, Student’s t test. B, analysis of relative hZTL1 mRNA levels (222 bp) expressed as a ratio of 18 S rRNA levels (489 bp)
in JAR cells. C, analysis of relative metallothionein mRNA levels (186 bp) expressed as a ratio of 18 S rRNA levels (489 bp) in Caco-2 cells; ***,
p  0.001, Student’s t test. D, analysis of relative metallothionein mRNA levels (186 bp) expressed as a ratio of 18 S rRNA levels (489 bp) in JAR
cells; ***, p  0.001, Student’s t test.
HZTL1, a Human Apical Intestinal Zinc Transporter 22795
Although hZTL1-induced zinc uptake appears modest in com-
parison with endogenous values for oocyte zinc transport, the
level of stimulation is commensurate with the apparent activ-
ity of the macrophage zinc transporter Nramp1 when ex-
pressed in Xenopus oocytes (23). Potential mechanisms other
than direct hZTL1-mediated flux across the oocyte plasma
membrane that might result in increased zinc uptake are stim-
ulation of endogenous plasma membrane zinc transport mech-
anisms or influx by mass action after hZTL1-mediated intra-
cellular sequestration. Both possibilities can be excluded on the
basis that endogenous and hZTL1-stimulated zinc uptake have
distinct pH profiles. The observed increase in hZTL1-mediated
Zn2 uptake between 12 and 50 M indicates a high Km. Based
on an estimate of 2.5 liters as the volume of fluid passing
through the intestine daily (42) and an average daily intake of
12 mg of zinc (43), we calculate the zinc concentration of the
intestinal lumenal contents after a meal to be in the order of
100 M, commensurate with a low affinity uptake mechanism.
Calculation of intracellular oocyte zinc concentration after
hZTL1-mediated Zn2 transport indicates that uptake is accu-
mulative. Most intracellular zinc, however, is protein-bound
(44); thus, any calculated apparent intracellular accumulation
of Zn2 may be an overestimate. Failure to identify a nucleo-
tide binding motif in the peptide sequence of hZTL1 indicates
that ion coupling rather than ATP hydrolysis is likely to be the
energy source for any net Zn2 transport by the carrier against
an electrochemical gradient. A proton electrochemical gradient
across the apical plasma membrane of the enterocyte, deriving
from the luminal acid pH microclimate adjacent to the brush
border membrane (45), provides the energy source for a number
of proton-coupled nutrient transporters (16, 46, 47). The nature
of the pH dependence of hZTL1-mediated zinc uptake, how-
ever, is inconsistent with proton co-transport. The small ob-
served increase in uptake at alkaline pH might be due to
protonation of specific amino acid residues in the polypeptide
chain or to proton countertransport (the latter made energeti-
cally favorable by the movement of a positively charged Zn2
species in the direction favored by the membrane potential).
Reduced uptake of zinc in the presence of an inwardly directed
pH gradient, as shown by our data for hZTL1, was observed
also in small intestinal brush border membrane vesicles (18),
consistent with the expression of hZTL1 in this membrane and
a role in uptake of dietary Zn2 across the apical enterocyte
membrane.
The functional data we report confirm that hZTL1 can me-
diate Zn2 uptake across the plasma membrane. We do not
exclude at this stage the possibility that hZTL1 may transport
other divalent cations in addition to Zn2. Detailed functional
analysis of the transport properties of hZTL1 will be the focus
of future study.
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